Aptabridge Therapeutics, Inc. is creating next generation immunotherapies to tackle areas of high unmet medical need. We are developing a computationally driven drug design pipeline to rapidly develop immune modulators with favorable safety profiles. Our team is made of driven biotechnology experts who are driven to improve the outcomes of patients.
